|
|
Effects of Tricetaxine Hydrochloride Combined with Different Statins on Cardiac Function of Heart Failure with hypertension |
CHI Shao-li, LIU Yan, WANG Hai-bing, et al |
Section A, Cadre Ward, the No. 401 Hospital of the PLA, Qingdao, Shandong, 266000 |
|
|
Abstract 【Objective】To observe the effects of tricetaxine hydrochloride combined with different statins on cardiac function of heart failure with hypertension patients.【Methods】A total of 120 patients with heart failure who were treated with hypertension from August 2015 to March 2017 were randomly divided into the group A, the group B and the group C, with 40 patients of each group. The three groups were given conventional basic treatment, and oral tricamalt hydrochloride tablets 20mg, 3 times one day, and the A group, the B group and the C group were respectively given oral fluvastatin, simvastatin, and atorvastatin 20mg, 1 time one day. After 6 months of treatment, the efficacy of the three groups were compared; the left ventricular ejection fraction (LVEF), the left ventricular end diastolic diameter (LVEDD), and the left ventricular end-diastolic diameter (LVESD), and the left ventricular end-diastolic diameter (LVEDD) were detected by ultrasonic diagnostic apparatus; the systolic blood pressure (SBP) and the diastolic blood pressure (DBP) were measured by a standard pool mercury sphygmomanometer; the total cholesterol (TC), the triglyceride (TG), the low density lipoprotein cholesterol (LDL-C) and the high density lipoprotein cholesterol (HDL-C) were measured by automatic biochemical analyzer; and drug safety analyze.【Results】The results of rank sum test showed that there was significant difference between the three groups (P<0.05). Total effective rate of the group C was significantly higher than that of the group A (P<0.05);the LVEF and HDL-C of the three groups were significantly higher than those before treatment (P<0.05), the LVESD, LVEDD, SBP, DBP, TG, TC, and LDL-C were significantly lower than those before treatment (P<0.05);the levels of LVEF and HDL-C of the group C were significantly higher than those of the group A and B (P<0.05), the LVESD, LVEDD, TG, TC and LDL-C were significantly lower than those of the group A and B (P<0.05);the LVEF and HDL-C of the group B were significantly higher than those of the group A (P<0.05), the LVESD, LVEDD, TG, TC and LDL-C were significantly lower than those of the group A (P<0.05);there was no significant difference in SBP and DBP between the group A, B and C (P>0.05);there was no significant difference in the incidence of adverse reactions of the three groups (P>0.05).【Conclusion】Trimetazidine hydrochloride combined with statins is effective in the treatment of hypertensive heart failure. However, its combination with atorvastatin can significantly improve cardiac function and blood lipid level, and has the highest efficacy and safety.
|
Received: 26 October 2017
|
|
|
|
|
[1] Jaarsma T,Beattie JM,Ryder M,et al.Palliative care in heart failure[J].Eur J Heart Fail,2015,11(5):433-443. [2] 王志军,曹佳佳,刁增利,等.芪苈强心胶囊改善心肌梗死后心力衰竭患者的临床症状[J].中成药,2015,37(1):44-48. [3] 李本磊,方冬,钱成,等.他汀类药物治疗扩张型心肌病的Meta分析[J].中国循证心血管医学杂志,2016,8(7):781-785. [4] 吴春涛.盐酸曲美他嗪治疗缺血性心肌病慢性心力衰竭的临床疗效观察[J].中西医结合心脑血管病杂志,2016,14(7):676-678. [5] Caforio PLA,Marcolongo R,Basso C,et al.Clinical presentation and diagnosis of myocarditis[J].Heart,2015,101(16):1332-1344. [6] 周琦,张竹华,刘红旭,等.心脉隆注射液对重症心力衰竭病人血流动力学的作用分析[J].中西医结合心脑血管病杂志,2016,14(4):401-403. [7] Antoine S,Vaidya G,Imam H,et al.Pathophysiologic mechanisms in heart failure role of the sympathetic nervous system[J].Am J Med Sci,2017,353(1):27-30.[8] 曹腾,杨波,王家宁,等.间断静脉内注入左西孟旦对失代偿性心力衰竭疗效的Meta分析[J].循证医学,2016,16(1):53-59. [9] 易德茂,张娟,徐冬梅.阿托伐他汀联合曲美他嗪对冠心病患者心功能、氧化应激及炎症因子的影响[J].海南医学院学报,2017,23(5):631-634. [10] Biton Y,Goldenberg I,Kutyifa V,et al.Effects of statins on first and recurrent supraventricular arrhythmias in patients with mild heart failure[J].Am J Cardiol,2015,116(12):1869-1874. [11] 张义林,司马祎鋆,舒鹏钦,等.阿托伐他汀对急性冠脉综合征合并慢性肾功能不全患者的影响[J].心脑血管病防治,2017,17(4):315-317. [12] Harada PH,Cook NR,Cohen DE,et al.Relation of alanine aminotransferase levels to cardiovascular events and statin efficacy.[J].Am J Cardiol,2016,118(1):49-55. [13] Segal R,Pitt B,Wilson PP,et al.Effects of HMG-COA reductase inhibitors (statins) in patients with heart failure[J].Eur J Heart Fail,2015,2(S1):96-97.[14] 陶蕾,纪立伟,王艳春.他汀类药物对动脉粥样硬化的疗效研究[J].中国现代医学杂志,2017,27(14):93-98. [15] 黄睿,张锋,任景怡,等.不同剂量他汀类药物短期治疗后降脂效果及不良反应研究[J].中国心血管杂志,2015,20(1):29-33. |
|
|
|